Results 121 to 130 of about 7,307 (207)

The involvement of soluble epoxide hydrolase in the development of cardiovascular diseases through epoxyeicosatrienoic acids

open access: yesFrontiers in Pharmacology
Arachidonic acid (AA) has three main metabolic pathways: the cycloxygenases (COXs) pathway, the lipoxygenases (LOXs) pathway, and the cytochrome P450s (CYPs) pathway. AA produces epoxyeicosatrienoic acids (EETs) through the CYPs pathway.
Shan Jiang   +4 more
doaj   +1 more source

Downregulation of osteoclast differentiation and activation by the soluble epoxide hydrolase inhibition. [PDF]

open access: yesJ Pharmacol Exp Ther
Martins G   +7 more
europepmc   +1 more source

Inhibition of soluble epoxide hydrolase ameliorates renal injury in IgA nephropathy by restoring epoxyeicosatrienoic acids. [PDF]

open access: yesiScience
Yin HH   +18 more
europepmc   +1 more source

Soluble Epoxide Hydrolase Inhibitors Improve Cornea Alkali Wound Healing. [PDF]

open access: yesFASEB J
Lu X   +10 more
europepmc   +1 more source

Soluble epoxide hydrolase in the liver orchestrates abdominal aortic aneurysm formation in mice. [PDF]

open access: yesCommun Biol
Kim DS   +30 more
europepmc   +1 more source

A novel inhibitor of soluble epoxide hydrolase that adducts C521 is cardioprotective. [PDF]

open access: yesRedox Biol
Charles RL   +11 more
europepmc   +1 more source

Inactivation of the Phosphatase Activity of Soluble Epoxide Hydrolase Modulates SIRT3 and Attenuates Experimental Pulmonary Hypertension. [PDF]

open access: yesCompr Physiol
Leuillier M   +17 more
europepmc   +1 more source

Soluble epoxide hydrolase inhibition preserves alveolar bone in experimental periodontitis with estrogen deficiency. [PDF]

open access: yesFront Immunol
Ritter C   +12 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy